Brief: Alligator Bioscience Resolves On Directed Issue Of 18,585,000 Units
07/01/2026 12:57
Jan 7 (Reuters) - Alligator Bioscience AB ATORX.ST: RESOLVES ON DIRECTED ISSUE OF 18,585,000 UNITS SUBSCRIPTION PRICE IN COMPENSATION ISSUE IS SEK 0.40 PER UNIT DIRECTED ISSUE OF 28,132,473 WARRANTS TO FENJA CAPITAL Source text: ID:nMFN1sQCt Further company coverage: ATORX.ST (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Alligator Bioscience AB
See all newsBrief: Alligator Bioscience Q1 Net Loss SEK 1.4 Million
Sweden's Alligator Bioscience posts Q1 net profit, narrows operating loss
Brief: Alligator Bioscience Q1 EBIT SEK -17.8 Million
Brief: Alligator Bioscience Signs LoI With Unicancer For Phase 3 Mitazalimab Development
Brief: Exercise Of Warrants Brings Alligator Bioscience Net Proceeds Of SEK 12 Mln